Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral nerve stimulation & intrathecal pumps · Texas | Peripheral nerve stimulation & intrathecal pumps · Florida | |
|---|---|---|
| Surgeons, 2024 | 60 | 65 |
| Medicare fee-for-service cases | 4,698 | 3,941 |
| Growth since 2019 (Medicare FFS) | +15%/yr | +8.8%/yr |
| Forecast cases (Medicare FFS) | 9,310 in 2030 | 5,860 in 2030 |
| Forecast growth | +12%/yr to 2030 | +6.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.0 | 1.6 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 72% (+38 pts since 2019) | 74% (+19 pts since 2019) |
| Cases per surgeon | 78 | 61 |
| Top 10 surgeons' share | 39% | 49% |
| Surgeons growing | 4 | 2 |
| New since the base year | 17 | 13 |
| Likely to stop billing it | 9 by 2026 | 15 by 2026 |
| Forecast miss, 1 year (procedure) | 11% | 11% |
| Company payments per surgeon | $8,870 | $4,410 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.